Biography
He is affiliated to Marlene Shehata Pharmaceuticals situated at Southwestern Ontario, Canada. He has a number of publications including, "Aliskiren: Is Combination Therapy with Angiotensin Converting Enzyme Inhibitors (ACE-I) or Angiotensin Receptor Blockers (ARBS) still a Possibility?".
Research Interest
Smoking, Heart Diseases, Blood, Blood Cells, Blood Vessels, Blood Coagulation, Blood Disorders
Publications
-
Impact of Genetic Factors in Cardiovascular Disease
Short Communication: Int J Cardiol Res
DOI:
Sarah Chen